The Journal is included in Russian and International Library and Abstract Databases
Russain Science Index (Russia)
EBSCO
DOI Registration Agency (USA)

Change in the psychosocial status of type 2 diabetes mellitus patients losing weight (a pilot study)

DOI: https://doi.org/10.29296/25877305-2020-07-11
Issue: 
7
Year: 
2020

I. Pashkova; I. Gatskikh, Candidate of Medical Sciences; T. Potupchik, Candidate of Medical
Sciences; T. Shalda; A. Galaktionov; I. Obednina Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical
University

The authors have evaluated the psychosocial status of patients with type 2 diabetes mellitus (T2DM) during weight loss with the use of Reduxin Met. The data obtained from the SF-36 questionnaires suggest that weight loss in men and women positively affects the individual components of both their mental and physical health. Reduxin Met as a component of combination therapy for T2DM can be recommended for weight loss.

Keywords: 
endocrinology
obesity
diabetes mellitus
psychosocial status
Reduxin Met



References: 
  1. Ametov A.S., Prudnikova M.A. Rol' preparatov dlja snizhenija massy tela v poetapnom upravlenii saharnym diabetom tipa 2: fokus na sibutramin. Endokrinologija: Novosti. Mnenija. Obuchenie. 2017; 1: 52–9 [Ametov A.S., Prudnikova M.A. The Role of drugs for weight loss in the phased management of diabetes mellitus type 2: focus on sibutramine. Endocrinology: News. Opinions. Training. 2017; 1: 52–9 (in Russ.)].
  2. Amirdzhanova V.N., Gorjachev D.V., Korshunov N.I. i dr. Populjatsionnye pokazateli kachestva zhizni po oprosniku SF-36 (Rezul'taty mnogotsentrovogo issledovanija kachestva zhizni «Mirazh»). Nauchno-prakticheskaja revmatologija. 2008; 1: 36–48 [Amirdzhanova V.N., Goryachev D.V., Korshunov N.I. et al. Population indicators of quality of life according to SF-36 questionnaire (Results of multicenter study of quality of life «Mirage»). Scientific and practical rheumatology. 2008; 1: 36–48 (in Russ.)].
  3. Burkov S.G., Ivleva A.Ja. Izbytochnyj ves i ozhirenie – problema meditsinskaja, a ne kosmeticheskaja. Ozhirenie i metabolizm. 2010; 3: 15 [Burkov S.G., Ivleva A.Y. Overweight and obesity – a medical problem, not a cosmetic one. Obesity and metabolism. 2010; 3: 15 (in Russ.)].
  4. Gosudarstvennyj reestr lekarstvennyh sredstv [Gosudarstvennyi reestr lekarstvennykh sredstv (in Russ.)]. Rezhim dostupa / Available at: https://grls.rosminzdrav.ru/grls.aspx
  5. Ionova T.I., Novik A.A. Rukovodstvo po issledovaniju kachestva zhizni v meditsine. Pod red. Ju.L. Shevchenko. 2-e izd. M.: OLMAPRESS, 2007 [Ionova T.I., Novik A.A. Rukovodstvo po issledovaniyu kachestva zhizni v meditsine. Pod red. Yu.L. Shevchenko. 2-e izd. M.: OLMAPRESS, 2007 (in Russ)].
  6. Lipchina O.I. Korrektsija metabolicheskih narushenij i pischevogo povedenija u patsientov s ozhireniem na fone priema kombinatsii preparatov Reduksin® (sibutramin+MKTs) i metformin v ramkah Vserossijskoj nabljudatel'noj programmy «PrimaVera». Endokrinologija: Novosti. Mnenija. Obuchenie. 2015; 2: 447 [Lipchina O.I. Correction of metabolic disorders and eating behavior in patients with obesity on the background of receiving a combination of drugs reducsin (sibutramine+MCC) and Metformin in the framework of the all-Russian observation program «Primavera». Endocrinology: News. Opinions. Training. 2015; 2: 44–7 (in Russ)].
  7. Romantsova T.I. Epidemija ozhirenija: ochevidnye i verojatnye prichiny. Ozhirenie i metabolizm. 2011; 1: 5–17 [Romantsova T.I. obesity Epidemic: obvious and probable causes. Obesity and metabolism. 2011; 1: 5–17 (in Russ.)].
  8. Samojlova Ju.G., Rotkank M.A., Zhukova N.G. i dr. Variabel'nost' glikemii u patsientov s saharnym diabetom 1-go tipa: svjaz' s kognitivnoj disfunktsiej i dannymi magnitno-rezonansnyh metodov issledovanija. Problemy endokrinologii. 2018; 64 (5): 286–91 [Samoilova I.G., Rotkank M.A., Zhukova N.G. et al. Variability of glycemia in patients with type 1 diabetes mellitus: the relationship with cognitive dysfunction and the results of magnetic resonance imaging. Problems of endocrinology (archive until 2020). 2018; 64 (5): 286–91. (in Russ.)]. https://doi.org/10.14341/probl9589
  9. Shostak N.A., Klimenko A.A., Shemenkovoj V.S. i dr. Ispol'zovanie oprosnika SF-36 v otsenke kachestva zhizni u patsientov s hronicheskoj tromboembolicheskoj legochnoj gipertenziej. Klinitsist. 2017; 3–4: 44–9 [Shostak N.A., Klimenko A.A., Shemenkova V.S. et al. the use of the SF-36 questionnaire in assessing the quality of life in patients with chronic thromboembolic pulmonary hypertension. Clinician. 2017; 3–4: 44–9 (in Russ.)]. DOI: 10.17650/1818-8338-2017-11-3-4-44-49
  10. Erdes Sh., Erdes K.Sh. Voprosnik SF-36 i ispol'zovanie ego pri revmatoidnom artrite. Nauchno-prakticheskaja revmatologija. 2003; 2: 47–52 [Erdes S., Erdes K.S. SF-36 And its use in rheumatoid arthritis. Scientific and practical rheumatology. 2003; 2: 47–52 (in Russ.)].
  11. 36-Item Short Form Survey (SF-36). URL: https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form.html